NAD+ Supplements: What Raises It, What It Changes, and What It Does Not

NAD+ is simultaneously the most oversold molecule in the supplement aisle and one of the best documented in the laboratory, and those two facts are not in conflict. The biochemistry is real: every cell you own runs on it, and the amount measured in human tissue falls with age. What is far less settled is the step the marketing skips over — whether swallowing a capsule that raises a laboratory number also changes how you feel, move or age. This guide keeps those two questions apart.

What NAD+ Actually Does in a Cell

Nicotinamide adenine dinucleotide — NAD+ — is a coenzyme present in every living cell. It has two jobs, and the second one is why age enters the story at all.

• It carries electrons. In the mitochondria, NAD+ shuttles electrons through the reactions that turn food into ATP. Without it, oxidative phosphorylation stops. This part is textbook and uncontroversial.
• It is consumed as a substrate. Two enzyme families — the sirtuins, and PARP, which repairs damaged DNA — do not merely use NAD+, they break it down. Every repair event spends some. That is what makes NAD+ a budget rather than a constant.

That budget appears to shrink over a lifetime. In human pelvic skin sampled from 49 people ranging from newborn to 77 years old, tissue NAD+ correlated negatively with age in both men and women, while PARP activity rose and correlated inversely with the NAD+ that remained (Massudi et al., 2012; PMID: 22848760). It is a cross-sectional correlation in one tissue, not a controlled experiment on ageing — but it is the human observation this entire category rests on, and it is worth knowing how narrow the base of the pyramid is.

Precursors: NR, NMN, and NAD+ Itself

You cannot meaningfully "eat NAD+" the way you eat protein. It is a large, charged molecule, and the established route into a cell is as a precursor that the cell rebuilds into NAD+ on arrival. The three names on nearly every label are not interchangeable, and their human evidence is not equal.

Human Evidence by Precursor

What the Human Trials Found — and What They Did Not

Three findings define the honest edge of this field, and they are worth reading in order, because together they tell a more useful story than any one of them alone.

The number moves. A single oral dose of NR raised blood NAD+ measurably in the first human pharmacokinetic study of the compound, with dose-dependent increases at 100, 300 and 1,000 mg (Trammell et al., 2016; PMID: 27721479). An eight-week randomised, double-blind, placebo-controlled trial in overweight adults then showed the increase holds: 22%, 51% and 142% at those same three doses, reached within two weeks and maintained, with no difference in adverse events versus placebo (Conze et al., 2019; PMID: 31278280).

The tissue responds. In aged men given 1 g of NR a day for 21 days, the skeletal muscle NAD+ metabolome rose and the muscle transcriptome shifted, including an anti-inflammatory signature (Elhassan et al., 2019; PMID: 31412242). Something is reaching the tissue and changing gene expression once it arrives.

The clinical outcome often does not. Forty obese, insulin-resistant men took 2,000 mg of NR a day for twelve weeks and were assessed by hyperinsulinaemic euglycaemic clamp — the reference method for insulin sensitivity. Insulin sensitivity, endogenous glucose production, glucose disposal, resting energy expenditure, lipolysis and body composition were all unchanged (Dollerup et al., 2018; PMID: 29992272). In healthy middle-aged and older adults, chronic NR was well tolerated and did stimulate NAD+ metabolism, but the authors' own conclusion was that future trials should assess blood pressure and arterial stiffness — not that a benefit had been demonstrated (Martens et al., 2018; PMID: 29599478).

The gap between "the biomarker rises" and "the person is better off" is the current state of the science. Anyone closing that gap for you in a headline is selling ahead of the evidence.

Where the Collagen Fits, and Where It Does Not

Collagen inside an NAD+ formula is a skin-and-joints ingredient sitting next to an energy-metabolism ingredient. They are not one mechanism and should not be described as one. The collagen evidence is its own literature: a systematic review and meta-analysis of 19 randomised, double-blind, controlled trials in 1,125 participants found hydrolyzed collagen improved skin hydration, elasticity and wrinkles versus placebo, with 90 days of daily use as the working minimum (de Miranda et al., 2021; PMID: 33742704).

The caveat applies to our own label as much as to anyone else's. Collagen trials in that literature dose in grams per day, not milligrams, and a 750 mg serving sits well below them. It is a real ingredient at a real, printed dose — it is not a substitute for a dedicated collagen dose, and we would rather write that here than let a meta-analysis do work the serving size cannot support.

What NAD+ Supplements Do Not Do

• They do not reverse ageing. No human trial has shown an NAD+ precursor extends lifespan or reverses any measure of biological age. The rodent literature is genuinely interesting; it is also rodent literature.
• They are not stimulants. There is no acute lift. If a product makes you feel something within the hour, read the label for caffeine or a B-vitamin megadose — that is what you are feeling.
• They do not fix insulin resistance. That was tested directly, at 2,000 mg a day for twelve weeks, with the reference method, and it did not (PMID: 29992272).
• They do not replace sleep, protein or training. Fatigue in someone sleeping six hours is a sleep problem, and NAD+ status is not the rate-limiting step in that life.
• They do not treat disease. Thyroid disease, iron-deficiency anaemia, sleep apnoea, depression and diabetes all present as low energy. Those need diagnosis, not a capsule.

How to Read an NAD+ Label

• Find the precursor, not the headline. "1,400 mg NAD+ complex" is a total. What you want is the milligrams of nicotinamide riboside or NMN on their own line.
• Check the serving size before comparing prices. A serving is often two or three capsules. Per-capsule and per-serving figures get mixed up constantly in reviews and comparison charts.
• "Proprietary blend" means the dose cannot be checked. A 1,000 mg blend can legally be 950 mg of the cheapest ingredient in it, which makes comparison against any trial impossible.
• Ask what "lab tested" covered. Identity, potency, heavy metals and microbials are four separate tests. A certificate of analysis naming the lot, the method and the result is worth paying for; a seal printed on a jar is not.
• Read the allergen line. Marine collagen means fish. That single line decides the product for a lot of people, and it is routinely buried.

Dose, Timing, and How Long to Give It

The figures below are the ones the cited trials used. They are a reference point for reading a label rather than a prescription, and worth raising with your own clinician if you take regular medication.

• NR: 300 mg a day is the sensible reference point. It raised whole-blood NAD+ by 51% over eight weeks (PMID: 31278280). The 1,000 mg arm raised it further, at roughly three times the cost.
• Morning, with food. No trial shows timing changes the result. Morning simply makes a daily habit easier to keep, and food reduces the mild nausea some people report.
• Give it eight to twelve weeks. Blood NAD+ moves inside two weeks; anything you might actually notice is downstream of that and slower.
• Judge it on something observable. Recovery between hard training sessions, the 4 p.m. dip, skin across three months. "Feeling more cellular energy" is not a measurement.

Questions People Actually Ask

NR or NMN — which one?

Both raise blood NAD+ in humans. NR has the longer trial record and the larger safety dataset; NMN sits one enzymatic step closer to NAD+ and has accumulated its own human safety and dose-response work (PMID: 31685720, 35479740). No head-to-head trial has established that either produces a clinical outcome the other does not, so anyone ranking them confidently is filling a gap in the data with an opinion.

Does oral NAD+ actually reach cells?

Not on the evidence available. The published human absorption work is on precursors, which is the honest reason to look for nicotinamide riboside on a label rather than to be reassured by a large "NAD+" number on the front of a jar.

Will I feel anything?

Possibly not, and that is a normal result rather than a defective bottle. In the trials, the reliable change is a laboratory value. Set the expectation there and you will make a better decision after three months than after three days.

I am 32. Is it too early?

The human data sit mostly in middle-aged and older adults, because that is where the decline was observed in the first place. There is no evidence of harm at these doses in younger adults, and no evidence of benefit either. At 32, sleep, resistance training and protein intake will out-earn any NAD+ precursor by a wide margin.

Does it help with weight or blood sugar?

The direct test says no — twelve weeks, 2,000 mg a day, no change in insulin sensitivity or body composition (PMID: 29992272). If metabolic support is the actual goal, the evidence base you want is a different one; start with our guide to berberine and what the blood-sugar trials show.

---

FDA & Medical Disclaimer: *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not a substitute for professional medical treatment.